469 related articles for article (PubMed ID: 14742676)
21. A MEK inhibitor, PD98059 enhances IL-1-induced NF-kappaB activation by the enhanced and sustained degradation of IkappaBalpha.
Funakoshi M; Tago K; Sonoda Y; Tominaga S; Kasahara T
Biochem Biophys Res Commun; 2001 Apr; 283(1):248-54. PubMed ID: 11322796
[TBL] [Abstract][Full Text] [Related]
22. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.
Yin L; Laevsky G; Giardina C
J Biol Chem; 2001 Nov; 276(48):44641-6. PubMed ID: 11572859
[TBL] [Abstract][Full Text] [Related]
23. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
Uehara T; Matsuno J; Kaneko M; Nishiya T; Fujimuro M; Yokosawa H; Nomura Y
J Biol Chem; 1999 May; 274(22):15875-82. PubMed ID: 10336492
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
Han Y; Weinman S; Boldogh I; Walker RK; Brasier AR
J Biol Chem; 1999 Jan; 274(2):787-94. PubMed ID: 9873017
[TBL] [Abstract][Full Text] [Related]
25. Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor.
Maggirwar SB; Harhaj E; Sun SC
Oncogene; 1995 Sep; 11(5):993-8. PubMed ID: 7675460
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of nuclear factor-kappaB activation induces apoptosis in cerebellar granule cells.
Piccioli P; Porcile C; Stanzione S; Bisaglia M; Bajetto A; Bonavia R; Florio T; Schettini G
J Neurosci Res; 2001 Dec; 66(6):1064-73. PubMed ID: 11746438
[TBL] [Abstract][Full Text] [Related]
27. Nuclear factor (NF)-kappa B blockade attenuates but does not abrogate LPS-mediated interleukin (IL)-1 beta biosynthesis in alveolar epithelial cells.
Haddad JJ
Biochem Biophys Res Commun; 2002 Apr; 293(1):252-7. PubMed ID: 12054592
[TBL] [Abstract][Full Text] [Related]
28. Endotoxin stress-response in cardiomyocytes: NF-kappaB activation and tumor necrosis factor-alpha expression.
Wright G; Singh IS; Hasday JD; Farrance IK; Hall G; Cross AS; Rogers TB
Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H872-9. PubMed ID: 11834481
[TBL] [Abstract][Full Text] [Related]
29. Proteasome inhibitors stimulate interleukin-8 expression via Ras and apoptosis signal-regulating kinase-dependent extracellular signal-related kinase and c-Jun N-terminal kinase activation.
Wu HM; Wen HC; Lin WW
Am J Respir Cell Mol Biol; 2002 Aug; 27(2):234-43. PubMed ID: 12151316
[TBL] [Abstract][Full Text] [Related]
30. Inhibition versus induction of apoptosis by proteasome inhibitors depends on concentration.
Lin KI; Baraban JM; Ratan RR
Cell Death Differ; 1998 Jul; 5(7):577-83. PubMed ID: 10200512
[TBL] [Abstract][Full Text] [Related]
31. Nuclear factor-kappa B-independent regulation of lipopolysaccharide-mediated interleukin-6 biosynthesis.
Haddad JJ; Fahlman CS
Biochem Biophys Res Commun; 2002 Mar; 291(4):1045-51. PubMed ID: 11866471
[TBL] [Abstract][Full Text] [Related]
32. Implications of proteasome inhibition: an enhanced macrophage phenotype.
Cuschieri J; Gourlay D; Garcia I; Jelacic S; Maier RV
Cell Immunol; 2004 Feb; 227(2):140-7. PubMed ID: 15135296
[TBL] [Abstract][Full Text] [Related]
33. Proteasome regulation of Fas ligand cytotoxicity.
Matsui K; Omura S; Cui H; Schauer SL; Sonenshein GE; Ju ST
Eur J Immunol; 1997 Sep; 27(9):2269-78. PubMed ID: 9341769
[TBL] [Abstract][Full Text] [Related]
34. Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.
Adam E; Quivy V; Bex F; Chariot A; Collette Y; Vanhulle C; Schoonbroodt S; Goffin V; Nguyên TL; Gloire G; Carrard G; Friguet B; De Launoit Y; Burny A; Bours V; Piette J; Van Lint C
Mol Cell Biol; 2003 Sep; 23(17):6200-9. PubMed ID: 12917341
[TBL] [Abstract][Full Text] [Related]
35. Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor.
Wang XC; Jobin C; Allen JB; Roberts WL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):477-86. PubMed ID: 9950608
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation.
Meyer S; Kohler NG; Joly A
FEBS Lett; 1997 Aug; 413(2):354-8. PubMed ID: 9280312
[TBL] [Abstract][Full Text] [Related]
37. Nuclear factor-kappaB p65 and upregulation of interleukin-6 in retinal ischemia/reperfusion injury in rats.
Wang J; Jiang S; Kwong JM; Sanchez RN; Sadun AA; Lam TT
Brain Res; 2006 Apr; 1081(1):211-8. PubMed ID: 16530172
[TBL] [Abstract][Full Text] [Related]
38. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
Shen X; Tian Z; Holtzman MJ; Gao B
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
[TBL] [Abstract][Full Text] [Related]
39. Proteasome inhibitors impair RANKL-induced NF-kappaB activity in osteoclast-like cells via disruption of p62, TRAF6, CYLD, and IkappaBalpha signaling cascades.
Ang E; Pavlos NJ; Rea SL; Qi M; Chai T; Walsh JP; Ratajczak T; Zheng MH; Xu J
J Cell Physiol; 2009 Aug; 220(2):450-9. PubMed ID: 19365810
[TBL] [Abstract][Full Text] [Related]
40. Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites.
Sun SC; Maggirwar SB; Harhaj E
J Biol Chem; 1995 Aug; 270(31):18347-51. PubMed ID: 7629157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
